COVID-19患者降钙素原水平:单中心研究

IF 0.4 Q3 MEDICINE, GENERAL & INTERNAL

Rawal Medical Journal Pub Date : 2023-01-01 DOI:10.5455/rmj.20230909063447

Batool Mahdi

{"title":"COVID-19患者降钙素原水平:单中心研究","authors":"Batool Mahdi","doi":"10.5455/rmj.20230909063447","DOIUrl":null,"url":null,"abstract":"Objective: The study the association of procalcitonin (PCT) and c-reactive protein (CRP) levels in COVID-19 patients and it's role as a guide in progress and management of those patients. Methodology: This cross-sectional study analyzed 200 CIOVID-19 patients in a single privet center in Baghdad, Iraq from January 1, 2021 to January 1, 2022. Demographic data like age, sex, and clinical symptoms were recorded. High sensitivity CRP and PCT in the serum were measured via dry fluorescence immunoassay (Lansionbio-China). Results: Out of 200 patients, 50 had moderate Covid and 150 had severe disease. Mean serum PCT levels was 0.039±0.05 ng/mL in the moderate group (range 0.011-0.067) and 0.43±0.21 ng/mL in the severe group (range 0.211±0.513). Mean serum PCT and CRP levels were higher in severe patients than in moderate patients. Conclusions: PCT and CRP may be an indicator of disease severity in COVID-19.","PeriodicalId":20844,"journal":{"name":"Rawal Medical Journal","volume":"116 1","pages":"0"},"PeriodicalIF":0.4000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Procalcitonin Level In COVID-19 Patients: A single center study\",\"authors\":\"Batool Mahdi\",\"doi\":\"10.5455/rmj.20230909063447\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: The study the association of procalcitonin (PCT) and c-reactive protein (CRP) levels in COVID-19 patients and it's role as a guide in progress and management of those patients. Methodology: This cross-sectional study analyzed 200 CIOVID-19 patients in a single privet center in Baghdad, Iraq from January 1, 2021 to January 1, 2022. Demographic data like age, sex, and clinical symptoms were recorded. High sensitivity CRP and PCT in the serum were measured via dry fluorescence immunoassay (Lansionbio-China). Results: Out of 200 patients, 50 had moderate Covid and 150 had severe disease. Mean serum PCT levels was 0.039±0.05 ng/mL in the moderate group (range 0.011-0.067) and 0.43±0.21 ng/mL in the severe group (range 0.211±0.513). Mean serum PCT and CRP levels were higher in severe patients than in moderate patients. Conclusions: PCT and CRP may be an indicator of disease severity in COVID-19.\",\"PeriodicalId\":20844,\"journal\":{\"name\":\"Rawal Medical Journal\",\"volume\":\"116 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.4000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Rawal Medical Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5455/rmj.20230909063447\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rawal Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5455/rmj.20230909063447","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

摘要

目的:探讨降钙素原(PCT)与c反应蛋白(CRP)水平在COVID-19患者中的相关性及其对患者治疗和治疗的指导作用。方法:本横断面研究分析了2021年1月1日至2022年1月1日在伊拉克巴格达一个私人中心的200名covid -19患者。记录年龄、性别和临床症状等人口统计数据。采用干式荧光免疫法(Lansionbio-China)检测血清中高灵敏度CRP和PCT。结果:200例患者中，中度50例，重度150例。中度组平均血清PCT水平为0.039±0.05 ng/mL(范围0.011 ~ 0.067)，重度组平均血清PCT水平为0.43±0.21 ng/mL(范围0.211±0.513)。重症患者的平均血清PCT和CRP水平高于中度患者。结论:PCT和CRP可能是COVID-19病情严重程度的一个指标。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Procalcitonin Level In COVID-19 Patients: A single center study

Objective: The study the association of procalcitonin (PCT) and c-reactive protein (CRP) levels in COVID-19 patients and it's role as a guide in progress and management of those patients. Methodology: This cross-sectional study analyzed 200 CIOVID-19 patients in a single privet center in Baghdad, Iraq from January 1, 2021 to January 1, 2022. Demographic data like age, sex, and clinical symptoms were recorded. High sensitivity CRP and PCT in the serum were measured via dry fluorescence immunoassay (Lansionbio-China). Results: Out of 200 patients, 50 had moderate Covid and 150 had severe disease. Mean serum PCT levels was 0.039±0.05 ng/mL in the moderate group (range 0.011-0.067) and 0.43±0.21 ng/mL in the severe group (range 0.211±0.513). Mean serum PCT and CRP levels were higher in severe patients than in moderate patients. Conclusions: PCT and CRP may be an indicator of disease severity in COVID-19.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Rawal Medical Journal MEDICINE, GENERAL & INTERNAL-

CiteScore

0.70

自引率

0.00%

发文量

期刊介绍： RMJ is a general Medicine publication and accepts oorigial articles, editorials, case reports and commentaries. It aims to dessiminate medical knowldge to professional community.